{
    "organizations": [],
    "uuid": "6aca20f38cddb252020f2dee206233d66d4de23c",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-alembic-pharmaceuticals-gets-us-fd/brief-alembic-pharmaceuticals-gets-u-s-fda-nod-for-acyclovir-ointment-usp-5-pct-idUSFWN1RL01N",
    "ord_in_thread": 0,
    "title": "BRIEF-Alembic Pharmaceuticals Gets U.S. FDA Nod For Acyclovir Ointment USP, 5 Pct",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 9 (Reuters) - Alembic Pharmaceuticals Ltd:\n* SAYS CO RECEIVED U.S. FDA APPROVAL FOR ACYCLOVIR OINTMENT USP, 5 PERCENT Source text - bit.ly/2qiUKur Further company coverage:\n ",
    "published": "2018-04-09T11:35:00.000+03:00",
    "crawled": "2018-04-09T17:18:10.004+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "alembic",
        "pharmaceutical",
        "ltd",
        "say",
        "co",
        "received",
        "fda",
        "approval",
        "acyclovir",
        "ointment",
        "usp",
        "percent",
        "source",
        "text",
        "company",
        "coverage"
    ]
}